Dermatological device developer Kleresca said today that it has been certified by the Medical Device Single Audit Program (MDSAP), boosting its plan to enter new markets. The audit gave Kleresca regulatory clearance to enter the medical device markets of Australia and Canada. With minor additional audits and approvals, the certification will also apply to Brazil, Japan, and the United States, […]